97071 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Albumins Serum albumin, e.g. HSA
METHOD FOR PREPARING HIGH-PURITY AND HIGH-STABILITY PROTEIN
#2COMPOSITIONS AND METHODS FOR ALPHA-1-ANTITRYPSIN DISORDERS
#3System and Method for Redirecting Audio and Video Data Streams in a Display-Server Computing System
#4Platelet lysate-based microparticles, methods and uses thereof
#5GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#6COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS
#7VIRAL VECTOR GENOME ENCODING AN INSULIN FUSION PROTEIN
#8ANTIGEN TOLERANCE INDUCTION THROUGH USE OF FLT3L VARIANTS
#9PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#10FUSION PROTEIN OF SERUM ALBUMIN AND PHYSIOLOGICALLY-ACTIVE PROTEIN
#11MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE
#12NOVEL FUSION PROTEIN FOR ELIMINATING NEURODEGENERATIVE DISEASE-CAUSING FACTOR AND USE THEREOF
#13Multifunctional Multispecific Multimeric Biomolecule Polymer Having Prolonged In-Vivo Duration
#14SYNTHESIS OF SELF-ASSEMBLING ARTIFICIAL PROTEINS UTILIZING A HOST-GUEST SYSTEM AND USES THEREOF
#15CLOSTRIDIUM BOTULINUM NEUROTOXIN SEROTYPE A COMPOSITIONS AND IMPROVED DRYING PROCESSES
#16METHODS OF PREPARING ALBUMIN PREPARATIONS
#17INSULIN FUSION PROTEIN
#18RECOMBINANT HUMAN SERUM ALBUMIN-COLLAGEN BINDING DOMAIN FUSION PROTEIN FOR TUMOR-SPECIFIC TARGETING MATRIX, AND USE THEREOF
#19FGF21 VARIANTS
#20Carrier-Binding Agent Compositions and Methods of Making and Using the Same
#21ALBUMIN PROTEIN VARIANTS, PRODUCTION THEREOF AND USES OF SAME
#22FCRN ANTAGONISTS WITH IMPROVED HALF-LIFE AND METHODS OF USE
#23COMPOSITIONS AND METHODS OF TREATING TISSUE DAMAGE
#24NUCLEIC ACID MOLECULES ENCODING NUCLEASE-ALBUMIN FUSION PROTEINS
#25BI- AND MULTIVALENT ALBUMIN BINDERS
#26FUSION PROTEIN OF INTERLEUKIN 2 AND APPLICATION THEREOF IN IBD
#27POROUS PROTEIN STRUCTURES
#28PREPARATION METHOD AND APPLICATION OF HIGH-PURITY PLANT-DERIVED RECOMBINANT HUMAN SERUM ALBUMIN
#29FAST, EASY, AND DIRECT AZIDYLATION OF BIOMOLECULES IN SOLUTION
#30SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#31Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors
#32Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor
#33IMPROVED PURIFICATION PROCESS
#34TRIMERIC ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHODS
#35PRODUCTS AND METHODS FOR ASSESSING AND INCREASING KLOTHO PROTEIN LEVELS
#36ACTIVE LOW MOLECULAR WEIGHT VARIANTS OF ANGIOTENSIN CONVERTING ENZYME 2 (ACE2)
#37APELIN RECEPTOR AGONISTS AND USES THEREOF
#38ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SELECTION
#39CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR USE IN THE TREATMENT AND PREVENTION OF RHEUMATOID ARTHRITIS
#40POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR
#41THERAPEUTIC RNA FOR TREATING CANCER
#42FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
#43REGENERATIVE POLYPEPTIDES AND USES THEREOF
#44LONG-ACTING RECOMBINANT HUMAN INTERLEUKIN-2 FUSION PROTEIN, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#45Single Protein-Encapsulated Biopolymers/Bio-oligomers for Therapeutic and Diagnostic Applications
#46PRINTED COMPOSITION FOR BIOMEDICAL USES
#47Modified plant endosperm specific promoter and use thereof
#48Preparation method and application of high-purity plant-derived recombinant human serum albumin
#49DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY
#50METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
#51Peptides And Methods For Detecting Egg Allergies
#52GDNF FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#53NANOPLATFORM FOR TARGETING MACROPHAGE AND COMPOSITION FOR PREVENTION OR TREATMENT OF METASTATIC CANCER
#54SYNTHESIS OF HUMAN SERUM ALBUMIN CONJUGATE
#55INTERLEUKIN 18 VARIANTS
#56INTRACELLULAR DELIVERY COMPOSITIONS
#57MODIFIED HUMAN SERUM ALBUMIN-THIOREDOXIN FUSION BODY
#58DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY
#59METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
#60DESIGNED ANKYRIN REPEAT DOMAIN WITH IMPROVED STABILITY
#61ANTICOAGULANT FUSION PROTEINS AND USES THEREOF
#62COMPOUNDS AND METHODS FOR EXTENDING HALF LIFE OF BIOMOLECULES
#63SEPARATION APPARATUS AND METHOD
#64PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES
#65IL-7 FUSION PROTEIN AND RELATED METHODS
#66Fusion Protein of Human Serum Albumin and Interleukin-2, and Use Thereof
#67CHEESE FOOD COMPOSITIONS
#68AN INTERLEUKIN-1 RECEPTOR ANTAGONIST AND A FUSION PROTEIN CONTAINING THE SAME
#69Modified plant endosperm specific promoter and use thereof
#70RECOMBINANT FUSION PROTEIN FOR PREVENTING OR TREATING FIBROTIC DISEASES
#71Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use
#72COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS
#73RE-FOLDED HUMAN SERUM ALBUMIN AND USE THEREOF FOR ANTI-TUMOR
#74METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS
#75METHOD FOR PURIFICATION OF RECOMBINANT PROTEINS
#76Antibodies and methods for making and using the same
#77EXTRACELLULAR VESICLES WITH IMPROVED HALF-LIFE
#78COMPOSITIONS COMPRISING PCSK9-BINDING MOLECULES AND METHODS OF USE
#79COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS
#80YOUNG AND UNDAMAGED HUMAN SERUM ALBUMIN IMPROVES LONGEVITY OF HUMAN
#81THERAPEUTIC FUSION PROTEINS
#82MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE
#83THERAPEUTIC FUSION PROTEINS
#84ABERRANT POST-TRANSLATIONAL MODIFICATIONS (PTMS) IN METHYL- AND PROPIONIC ACIDEMIA AND A MUTANT SIRTUIN (SIRT) TO METABOLIZE PTMS
#85METHOD FOR POLISHING ALBUMIN
#86BISPECIFIC ANTIBODIES AGAINST CD9 AND CD137
#87FAST-OFF RATE SERUM ALBUMIN BINDING FIBRONECTIN TYPE III DOMAINS
#88SHEDDING BLOCKING AGENTS WITH INCREASED STABILITY
#89GDF15 FUSION PROTEINS AND USES THEREOF
#90A NOVEL WASH BUFFER SOLUTION FOR AFFINITY CHROMATOGRAPHY
#91Chromatographic methods for purification of proteins from plasma
#92HUMAN SERUM ALBUMIN VARIANTS AND USES THEREOF
#93SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS AND USES THEREOF
#94Albumin variants and conjugates
#95COMPOSITIONS AND METHODS FOR STROKE PREVENTION IN PEDIATRIC SICKLE CELL ANEMIA PATIENTS
#96NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF
#97MATE AND SEPARATE: A CONVENIENT AND GENERAL METHOD FOR THE SEPARATION AND PURIFICATION OF TARGET MOLECULES FROM BIOLOGICAL MEDIA BY PHASE TRANSITION OF PEGYLATED RECOGNITION AGENTS.
#98Heparin-Associated Polypeptides and Uses Thereof
#99COMPOSITIONS, METHODS AND USES FOR FREE FATTY ACID SCREENING OF CELLS AT SCALE
#100PROTEIN-BASED BIOMATERIAL WITH VISCOELASTIC BEHAVIOUR, PROCESS FOR OBTAINING IT AND USES THEREOF
#101GDF15 ANALOGS AND METHODS FOR USE IN DECREASING BODY WEIGHT AND/OR REDUCING FOOD INTAKE
#102PROTEIN AND METABOLITE ENRICHMENT USING FOCUSED ACOUSTIC ENERGY
#103CELL FREEZING MEDIUM FOR CLINICAL USE
#104IMPROVED BUFFER FOR THE CAPACITATION OF SPERMATOZOA
#105Artificial protein catalyst
#106BISPECIFIC BINDING CONSTRUCTS WITH SELECTIVELY CLEAVABLE LINKERS
#107COMPOSITIONS COMPRISING ALBUMIN-FMS-LIKE TYROSINE KINASE 3 LIGAND FUSION PROTEINS AND USES THEREOF
#108CARRIER-BINDING AGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
#109Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens
#110Mut- methylotrophic yeast
#111COMPOSITIONS AND METHODS TO MANUFACTURE TUMOR SUPPRESSOR FUSIONS
#112Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
#113NEW RECOMBINANT DIAMINE OXIDASE AND ITS USE FOR THE TREATMENT OF DISEASES CHARACTERIZED BY EXCESS HISTAMINE
#114RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN
#115PLASMA FRACTIONATION UTILIZING SPRAY-DRIED HUMAN PLASMA
#116DETERGENT-MIXED DRY HYDROGEL PARTICLE AND CONCENTRATION AND SPECIFIC ACTIVITY ENHANCEMENT OF MACROMOLECULE
#117Fusion albumin nanoparticle and application thereof
#118Materials and methods of using engineered ligands
#119COMPOSITIONS COMPRISING THE PROPEPTIDE OF LYSYL OXIDASE AND USES THEREOF
#120Albumin compositions and methods of producing and using same
#121MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS AND USES THEREOF FOR THE TREATMENT OF DISEASES
#122Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
#123Methods and reagents for modulating macrophage phenotype
#124ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES FOR DRUG CANDIDATE SELECTION
#125BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF
#126POLYMER, SEPARATING AGENT, PRODUCTION METHOD OF POLYMER, SEPARATION METHOD OF COMPOUND, AND PRODUCTION METHOD OF COMPOUND
#127METHOD OF TREATING ATHEROSCLEROSIS
#128Bi-specific therapeutic proteins, in vivo methods of use thereof and encoding nucleic acids thereof
#129METHODS OF PURIFICATION OF ALBUMIN FUSION PROTEINS
#130PREPARATION AND/OR FORMULATION OF PROTEINS CROSS-LINKED WITH POLYSACCHARIDES
#131Method for producing organic sulfur compound, carrier, method for producing said carrier, ligand-immobilizing carrier, chromatography column, and method for detecting or isolating target substance
#132COMPOSITIONS AND METHODS FOR ALPHA-1-ANTITRYPSIN DISORDERS
#133Compositions and Methods of Use for Treating Metabolic Disorders
#134PROTOXIN-II VARIANTS AND METHODS OF USE
#135Nucleic acid molecules encoding nuclease-albumin fusion proteins
#136Anti-mesothelin constructs and uses thereof
#137PLANT MATTER SMOKE AND VAPOR COLLECTION DEVICE
#138Human serum albumin mutant
#139BLOOD-BRAIN BARRIER TRANSMIGRATING THERAPEUTIC COMPOUNDS AND USES THEREOF
#140Multiple specificity binders of CXC chemokines
#141Cytokine-albumin binding moiety fusion proteins and uses thereof
#142MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#143MODIFIED UROKINASE-TYPE PLASMINOGEN ACTIVATOR POLYPEPTIDES AND METHODS OF USE
#144FORMULATIONS FOR SIMIAN ADENOVIRAL VECTORS HAVING ENHANCED STABILITY
#145ALBUMIN-PROAEROLYSIN PRODRUGS
#146RECOMBINANT FUSION PROTEINS FOR PREVENTING OR TREATING ADHESIONS OF TISSUES OR ORGANS
#147POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCγ RECEPTORS
#148Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use
#149Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes
#150Method for purification of albumin
#151Compositions and methods to manufacture tumor suppressor fusions
#152ALBUMIN VARIANTS AND CONJUGATES
#153Anticoagulant fusion proteins and uses thereof
#154TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS THAT BIND EGFR
#155Composition and Use of Humoral Immune Suppressor Antagonists for the Treatment of Humoral Immune Suppressed Diseases
#156Environmentally compatible detergents for inactivation of lipid-enveloped viruses
#157Serpin fusion polypeptides and methods of use thereof
#158Fusion Molecules Targeting Immune Regulatory Cells and Uses Thereof
#159FOOD COMPOSITIONS COMPRISING MILK PROTEINS PRODUCED IN TRANSGENIC PLANTS
#160MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS
#161Serpin fusion polypeptides and methods of use thereof
#162Compositions comprising PCSK9-binding molecules and methods of use
#163Method of purifying albumin-fusion proteins
#164Albumin variants and conjugates
#165ALBUMIN VARIANTS
#166T cells surface-loaded with immunostimulatory fusion molecules and uses thereof
#167Human serum albumin variants and uses thereof
#168Method for Detecting Human Soluble Asialoglycoprotein Receptor
#169ALBUMIN VARIANTS FOR ENHANCED SERUM HALF-LIFE
#170Fast-off rate serum albumin binding fibronectin type III domains
#171DKK2 CYSTEINE RICH DOMAIN 2 CONTAINING PROTEINS AND USES THEREOF
#172NUCLEIC ACID CONSTRUCTS AND METHODS OF USE
#173Albumin-proaerolysin prodrugs
#174Human serum albumin mutant
#175Preparation and/or formulation of proteins cross-linked with polysaccharides
#176METHOD FOR POLISHING ALBUMIN
#177Modified urokinase-type plasminogen activator polypeptides and methods of use
#178Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5
#179YEAST EXPRESSING A SYNTHETIC CALVIN CYCLE
#180Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
#181Compositions and methods for stroke prevention in pediatric sickle cell anemia patients
#182HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF
#183CTLA4 binders
#184Conjugate and block copolymer containing fluorescent chromophore and preparation method therefor and use thereof
#185METHODS OF PURIFICATION OF ALBUMIN FUSION PROTEINS
#186MILK PROTEIN PRODUCTION IN TRANSGENIC PLANTS
#187Chimeric antibody immune effector cell engagers and methods of use thereof
#188GLP-1 ANALOG FUSION PROTEIN AND PREPARATION METHOD AND APPLICATION THEREOF
#189SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF
#190ALBUMIN VARIANTS
#191Albumin variants
#192Methods for treatment of nephrotic syndrome and related conditions
#193PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#194Compositions and Methods of Use For Treating Metabolic Disorders
#195Fusion protein Slit2D2(C386S)-HSA and use thereof in prevention and/or treatment of lung inflammation
#196Compositions comprising PCSK9-binding molecules and methods of use
#197IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#198Protoxin-II variants and methods of use
#199Antibodies and methods for making and using the same
#200FC receptor (FcRn) binding peptides and uses thereof
#201Multivalent heteromultimer scaffold design and constructs
#202Method for efficient purification of human serum albumin
#203Polypeptides targeting HIV fusion
#204Cell freezing medium for clinical use
#205USES OF MODIFIED MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#206CONSTRUCTION OF ENGINEERING BACTERIA FOR HIGH EXPRESSION OF RECOMBINANT HUMAN SERUM ALBUMIN
#207ALBUMIN VARIANTS
#208Method of treating atherosclerosis
#209Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases
#210Lactoferrin/albumin fusion protein and production method therefor
#211Fibronectin based scaffold domain proteins that bind to myostatin
#212GDF15 fusion proteins and uses thereof
#213Methods and reagents for modulating macrophage phenotype
#214GDNF fusion polypeptides and methods of use thereof
#215Truncated von Willebrand Factor polypeptides for treating hemophilia
#216Use of electrochemical devices or systems comprising redox-functionalized electrodes for bioseparation and biocatalysis
#217USES OF RECOMBINANT YEAST-DERIVED SERUM ALBUMIN
#218Compositions comprising albumin-FMS-like tyrosine kinase 3 ligand fusion proteins and uses thereof
#219Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
#220BLOCKADE OF ALPHAFETOPROTEIN (AFP) INTERACTIONS WITH BETA2-MICROGLOBULIN ASSOCIATED MOLECULES
#221Small molecule dye for molecular imaging and photothermal therapy
#222FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
#223PRODUCTS AND METHODS FOR ASSESSING AND INCREASING KLOTHO PROTEIN LEVELS
#224Human serum albumin binding compounds and fusion proteins thereof
#225Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5
#226Generation of stable protein films using fluorous solvent
#227Albumin variants and uses thereof
#228Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
#229Multivalent heteromultimer scaffold design and constructs
#230PHARMACOKINETIC ANIMAL MODEL
#231METHODS FOR MODULATING INTESTINAL MICROBIOTA
#232Conjugates, their compositions, their uses, and their methods of making
#233Methods of using therapeutic p53 peptides
#234Kv1.3 Antagonists and Methods of Use
#235Ligand functional substrates
#236Technology for the Preparation of Microparticles
#237Fusion proteins and their related methods
#238Bispecific antibody platform
#239Serum albumin-20K growth hormone fusion protein
#240Fusion protein for alpha-melanocyte stimulating hormone and preparation method and use thereof
#241FGF21 variants
#242Variant serum albumin with improved half-life and other properties
#243Albumin variants
#244Albumin variants
#245Albumin variants and conjugates
#246Fast-off rate serum albumin binding fibronectin type III domains
#247Targeted therapeutics based on engineered proteins that bind EGFR
#248Human serum albumin mutant
#249Method for producing interleukin-2 protein using methylotrophic yeast
#250Carrier-binding agent compositions and methods of making and using the same
#251Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
#252ALBUMIN VARIANTS
#253ALBUMIN FUSION PROTEINS
#254Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
#255Albumin-sugar chain complex
#256Process for enhanced production of recombinant human serum albumin in through chaperone assistance
#257Serpin fusion polypeptides and methods of use thereof
#258Slit2D2-HSA fusion protein and use thereof against tumours
#259ALBUMIN VARIANTS
#260Expression sequences
#261Chromatographic methods for purification of proteins from plasma
#262PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC ACTIVITY
#263Polypeptides targeting HIV fusion
#264ALBUMIN VARIANTS
#265ALBUMIN VARIANTS
#266ALBUMIN VARIANTS
#267Method of purifying albumin-fusion proteins
#268Compositions and methods of use for treating metabolic disorders
#269Compositions and methods of use for treating metabolic disorders
#270Fusion protein SLIT2D2-HSA and its use in treatment of sepsis
#271Long-lived polynucleotide molecules
#272A SOLUBLE CHIMERIC INTERLEUKIN-10 RECEPTOR AND THERAPEUTIC USE THEREOF
#273ALBUMIN VARIANTS
#274Rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjunction therewith
#275NOVEL ANTIBODY-ALBUMIN-DRUG CONJUGATES (AADC) AND METHODS FOR USING THEM
#276Method of preparing an anti-serum albumin Fab-effector moiety fusion construct
#277IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#278Interleukin-2 expression construct using human serium albumin
#279Technology for the Preparation of Microparticles
#280Albumin-proaerolysin prodrugs
#281Fibronectin based scaffold domain proteins that bind to myostatin
#282Optimized cross-species specific bispecific single chain antibody contructs
#283Method for efficient purification of human serum albumin
#284COMPOSITIONS AND METHODS OF TREATING DISEASE WITH FGFR FUSION PROTEINS
#285Chromatography device and method for filtering a solute from a fluid
#286MT-45 IMMUNODETECTION
#287Protoxin-II variants and methods of use
#288REAGENT KIT AND METHOD FOR REMOVING BACTERIAL ENDOTOXIN IN BIOLOGICAL PRODUCT
#289GDF15 fusion proteins and uses thereof
#290Fusion protein comprising albumin and retinol-binding protein
#291Recombinant fusion proteins for preventing or treating adhesions of tissues or organs
#292BLOOD-BRAIN BARRIER DISRUPTING AGENTS AND USES THEREOF
#293HUMAN SERUM ALBUMIN LINKERS AND CONJUGATES THEREOF
#294HSA-GDF-15 FUSION POLYPEPTIDE AND USE THEREOF
#295Preparation and/or formulation of proteins cross-linked with polysaccharides
#296Methods of treating cancer by administering IGF-IR binding molecules
#297Multivalent heteromultimer scaffold design and constructs
#298Amino acid sequences directed against RANK-L and polypeptides comprising the same for the treatment of bone diseases and disorders
#299Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the same
#300Device, use of said device, and method for separating substances with an improved utilization of the capacity of chromatographic media